Swiss National Bank’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.1M Buy
129,055
+9,500
+8% +$2.73M 0.02% 496
2025
Q1
$36.9M Buy
119,555
+100
+0.1% +$30.8K 0.03% 483
2024
Q4
$42.1M Sell
119,455
-5,600
-4% -$1.98M 0.03% 464
2024
Q3
$44.8M Sell
125,055
-7,300
-6% -$2.62M 0.03% 470
2024
Q2
$42.2M Sell
132,355
-8,300
-6% -$2.64M 0.03% 454
2024
Q1
$32.3M Sell
140,655
-6,100
-4% -$1.4M 0.02% 536
2023
Q4
$32.3M Sell
146,755
-3,900
-3% -$858K 0.02% 535
2023
Q3
$34M Sell
150,655
-16,500
-10% -$3.73M 0.03% 514
2023
Q2
$36.9M Sell
167,155
-13,800
-8% -$3.05M 0.03% 526
2023
Q1
$40.5M Buy
180,955
+71,055
+65% +$15.9M 0.03% 509
2022
Q4
$30.6M Buy
109,900
+2,500
+2% +$695K 0.02% 557
2022
Q3
$22.5M Buy
107,400
+1,000
+0.9% +$209K 0.02% 606
2022
Q2
$25.1M Sell
106,400
-100
-0.1% -$23.6K 0.02% 592
2022
Q1
$19.1M Buy
106,500
+7,800
+8% +$1.4M 0.01% 696
2021
Q4
$21.3M Sell
98,700
-200
-0.2% -$43.2K 0.01% 672
2021
Q3
$18.3M Buy
98,900
+700
+0.7% +$129K 0.01% 707
2021
Q2
$17.6M Sell
98,200
-3,400
-3% -$610K 0.01% 742
2021
Q1
$17M Buy
101,600
+1,200
+1% +$201K 0.01% 734
2020
Q4
$15.2M Buy
100,400
+600
+0.6% +$91.1K 0.01% 736
2020
Q3
$10.1M Buy
99,800
+1,900
+2% +$192K 0.01% 799
2020
Q2
$11.8M Buy
97,900
+12,800
+15% +$1.55M 0.01% 713
2020
Q1
$8.07M Buy
85,100
+1,200
+1% +$114K 0.01% 731
2019
Q4
$7.39M Buy
83,900
+1,400
+2% +$123K 0.01% 925
2019
Q3
$6.58M Buy
82,500
+2,500
+3% +$199K 0.01% 950
2019
Q2
$6.25M Sell
80,000
-65,200
-45% -$5.09M 0.01% 978
2019
Q1
$17M Buy
145,200
+3,700
+3% +$434K 0.02% 606
2018
Q4
$15.4M Buy
141,500
+2,400
+2% +$261K 0.02% 586
2018
Q3
$17.8M Sell
139,100
-3,900
-3% -$499K 0.02% 601
2018
Q2
$16.2M Buy
143,000
+3,300
+2% +$373K 0.02% 610
2018
Q1
$15.7M Sell
139,700
-21,900
-14% -$2.46M 0.02% 611
2017
Q4
$23.9M Sell
161,600
-4,000
-2% -$592K 0.03% 572
2017
Q3
$19.4M Buy
165,600
+1,600
+1% +$188K 0.02% 583
2017
Q2
$21.3M Buy
164,000
+13,700
+9% +$1.78M 0.03% 579
2017
Q1
$20.3M Buy
150,300
+28,900
+24% +$3.91M 0.03% 570
2016
Q4
$17.4M Sell
121,400
-2,700
-2% -$387K 0.03% 562
2016
Q3
$14.7M Sell
124,100
-3,000
-2% -$354K 0.02% 573
2016
Q2
$13.5M Buy
127,100
+8,400
+7% +$890K 0.02% 589
2016
Q1
$12.7M Buy
118,700
+36,000
+44% +$3.84M 0.02% 580
2015
Q4
$13M Buy
82,700
+200
+0.2% +$31.3K 0.03% 519
2015
Q3
$10.8M Buy
82,500
+7,200
+10% +$945K 0.03% 545
2015
Q2
$13.1M Buy
75,300
+21,400
+40% +$3.72M 0.03% 508
2015
Q1
$9.29M Buy
53,900
+700
+1% +$121K 0.02% 578
2014
Q4
$6.89M Buy
53,200
+2,600
+5% +$337K 0.03% 573
2014
Q3
$6.51M Sell
50,600
-3,000
-6% -$386K 0.03% 573
2014
Q2
$4.74M Hold
53,600
0.02% 750
2014
Q1
$5.04M Buy
53,600
+12,000
+29% +$1.13M 0.02% 701
2013
Q4
$4.7M Buy
41,600
+400
+1% +$45.2K 0.02% 640
2013
Q3
$3.25M Sell
41,200
-1,100
-3% -$86.7K 0.01% 755
2013
Q2
$2.78M Buy
+42,300
New +$2.78M 0.01% 809